GWM
FLGT icon

Geneos Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Geneos Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-416
Closed -$12K – 2162
2023
Q4 		$12K Hold
416
– – ﹤0.01% 1503
2023
Q3 		$11.1K Hold
416
– – ﹤0.01% 1536
2023
Q2 		$15.4K Buy
416
+20
+5% +$697 ﹤0.01% 1456
2023
Q1 		$12.4K Sell
396
-20
-5% -$644 ﹤0.01% 1490
2022
Q4 		$12.4K Hold
416
– – ﹤0.01% 1474
2022
Q3 		$15K Sell
416
-75
-15% -$3.76K ﹤0.01% 1413
2022
Q2 		$27K Hold
491
– – ﹤0.01% 1543
2022
Q1 		$30K Buy
491
+396
+417% +$26.1K ﹤0.01% 1605
2021
Q4 		$9K Sell
95
-75
-44% -$6.59K ﹤0.01% 2212
2021
Q3 		$14K Buy
170
+20
+13% +$1.82K ﹤0.01% 2084
2021
Q2 		$13K Sell
150
-305
-67% -$24.4K ﹤0.01% 2095
2021
Q1 		$35K Hold
455
– – ﹤0.01% 1809
2020
Q4 		$43K Buy
+455
New +$19K ﹤0.01% 1533

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geneos Wealth Management's FLGT Position: Q1 2024 in Review

Geneos Wealth Management sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 416 shares — an estimated $12K sold.

Geneos Wealth Management first reported a position in FLGT in Q4 2020 and held it in 13 quarters. The position peaked at $43K in Q4 2020. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Geneos Wealth Management reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 416 Fulgent Genetics shares in Q1 2024, an estimated $12K.
  • Geneos Wealth Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 13 quarters.
  • Geneos Wealth Management's Fulgent Genetics position peaked at $43K in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.